REGN
REGN
NASDAQ · Biotechnology

Regeneron Pharmaceuticals

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$904.35
+1.45 (+0.16%)
As of Nov 7, 1:03 AM ET ·
Analyst Consensus
Buy
37
Analysts
Very High
Coverage
Buy 26 70%
Hold 11 30%
Sell 0 0%
Price Target
Analyst Price Target -91.5% upside
Low Target $61.79
Average Target $76.80
High Target $111.17
Current Price $904.35
Current
$904.35
Target
$76.80
$61.79 $76.80 avg $111.17
Scenario Analysis
Bear Case
$61.79
-93.2%
Low target
Base Case
$76.80
-91.5%
Avg target
Bull Case
$111.17
+-87.7%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$991.73
-8.8% from high
52-Week Low
$591.52
+52.9% from low
50-Day SMA
$804.38
+12.4% vs SMA
200-Day SMA
$742.33
+21.8% vs SMA
RSI (14)
70.3
Overbought
Target vs 52W High
$76.80
-92.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%